EUVIMEDEUVIMED entdecken
Open Access

CTPS1 is an unexplored vulnerability in breast and ovarian cancer

Xiyin Wang, Michael J Emch, Lauren A Voll, Rebecca Epp, Esther P B Rodman, Noa J Odell, Hannah M Smith, Nicole A Pearson, Xiaonan Hou, Ya Li, Melissa C Larson, Ann L Oberg und 6 weitere

Theranostics · 20.07.2026 · 16 (14) · 8195-8214

DOI: 10.7150/thno.134720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 20.07.2026. Verfasst von Xiyin Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Triple Negative Breast Neoplasms. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsTriple Negative Breast NeoplasmsHumansFemaleAnimalsCell Line, TumorMiceCell ProliferationXenograft Model Antitumor AssaysAntineoplastic Agents

Stichwörter der Autor:innen

CTPS1drug resistanceovarian cancertargeted therapytriple negative breast cancer

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.
  • Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Case Western Reserve University, Cleveland, OH, USA.
  • Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA, USA.
  • Department of Oncology, Mayo Clinic, Rochester, MN, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Wang, X., Emch, M. J., Voll, L. A., Epp, R., Rodman, E. P. B., Odell, N. J., Smith, H. M., Pearson, N. A., Hou, X., Li, Y., Larson, M. C., Oberg, A. L., Hitosugi, T., Goetz, M. P., Kaufmann, S. H., Weroha, S. J., Beer, P. A., & Hawse, J. R. (2026). CTPS1 is an unexplored vulnerability in breast and ovarian cancer. Theranostics, 16(14), 8195-8214. https://doi.org/10.7150/thno.134720

Vancouver

Wang X, Emch MJ, Voll LA, Epp R, Rodman EPB, Odell NJ, et al. CTPS1 is an unexplored vulnerability in breast and ovarian cancer. Theranostics. 2026;16(14):8195-8214. doi:10.7150/thno.134720

BibTeX
@article{Wang2026,
  author = {Wang, Xiyin and Emch, Michael J and Voll, Lauren A and Epp, Rebecca and Rodman, Esther P B and Odell, Noa J and Smith, Hannah M and Pearson, Nicole A and Hou, Xiaonan and Li, Ya and Larson, Melissa C and Oberg, Ann L and Hitosugi, Taro and Goetz, Matthew P and Kaufmann, Scott H and Weroha, S John and Beer, Philip A and Hawse, John R},
  title = {CTPS1 is an unexplored vulnerability in breast and ovarian cancer},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {14},
  pages = {8195--8214},
  doi = {10.7150/thno.134720}
}
Kostenlos starten →